Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier

Rice plant having vaccine gene transferred thereinto

Non-M, non-O HIV-1 strains, fragments and uses

Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to hiv

Animal model for HIV induced disease

Chimaeric vector system

HIV fusion inhibitor peptides with improved biological properties

Covalent attachment of ligands to nucleophilic proteins guided by non-covalent

Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins

Anti-hiv-1 compounds based upon a conserved amino acid sequence shared by gp160 and the human cd4 protein

Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence

Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation

process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereof

Immunogenic compositions comprising human immunodeficiency virus type 2 (HIV-2) glycosylated and unglycosylated envelope proteins and their methods of preparation

Alphavirus replicons and helper constructs

Adjuvant comprising non-toxic cross-linked muramyl dipeptide (MDP) microparticles derived from Propionibacterium acnes

Stabilizing peptides

CELL-BASED FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) ASSAYS FOR CLOSTRIDIAL TOXINS

Compositions and methods of treating retroviral infections

Method for the recombinant expression of a polypeptide

Reverse transfection of cell arrays for structural and functional analyses of proteins

Retrovirus from the HIV group and its use

Vaccines, immunotherapeutics and methods for using the same

Comparative ligand mapping from MHC positive cells

Viral deconstruction through capsid assembly in vitro

Multilayer films, coatings, and microcapsules comprising polypeptides

Multilayer films, coatings, and microcapsules comprising polypeptides

Immunogenic compositions and methods of use

Hiv polynucleotides and polypeptides derived from botswana mj4

Modified transferrin fusion proteins

Method for ameliorating pain by modification of NMDA receptors through inhibition of Src

Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications

Recombinant protein production in a human cell

Modified transferrin fusion proteins

Compositions and methods for generating an immune response

Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion

Vaccine

Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission

Chimeric retroviral Gag genes and screening assays

Method of making modified immunodeficiency virus particles

Potent combinations of mRNA transport elements

DNA vaccines encoding antigen linked to a domain that binds CD40

Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin

HIV DNA vaccine

Lentiviral packaging constructs

Compositions for modulating immune cell activity and methods for detection thereof

Aids ancestral viruses and vaccines

HIV-1 protein associated with broadly reactive neutralizing antibody response

Genome of the HIV-1 inter-subtype (C/B') and use thereof

Therapeutic peptides and vaccines

Method for preparating t-20 peptide by high cell density cultivation of recombinant e. coli containing t-20 peptide coding gene

Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41

Purification and characterization of soluble human HLA proteins

Methods for the production of peptide derivatives

Synthesis using peptide intermediate fragments

PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM

Albumin fusion proteins

HIV vaccines based on Env of multiple clades of HIV

Peptide oligomers for use as hiv vaccines

Recombinant double-stranded RNA phage, and use of the same

Modulation of cytokine signaling regulators and applications for immunotherapy

Influenza hemagglutinin and neuraminidase variants

Mannose immunogens for HIV-1

HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus

Use of HIV-1 gp120 and gp160 proteins modified in the V3 loop for the preparation of vaccine compositions and formulations containing the same

Hiv inhibiting proteins

Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

ANTI-HIV IMMUNOGENIC FORMULATION AND PROCESS FOR PREPARATION THEREOF

Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses

Novel mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism

Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector

Modified antiviral peptides with increased activity and cell membrane affinity

Gp120 specific antigens and uses thereof

Prostate specific antigens and uses thereof

Virus vaccine

Compositions and methods for delivery of genetic material

Peptides for the detection of HIV-1 group O

Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

Immunogen

Albumin fusion proteins

Methods and compositions for colorimetrically assessing peptide characteristics

Synthesis using peptide intermediate fragments

Methods and compositions for preparing peptides with excellent solubility characteristics in aqueous solution at physiological pH

Gp41 inhibitor

Method of inducing an enhanced immune response against hiv

Multiple branch peptide construction

Compositions and methods related to modified retroviral vectors for restricted, site specific integration

Antigen constructs useful in the detection and differentiation of antibodies to HIV

Antigenic peptides

Recombinant double-stranded RNA phages and uses thereof

Vaccine

Pharmaceutical compositions comprising an hiv envelope protein and cd4

Genetic constructs and compositions comprising RRE and CTE and uses thereof

Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion

Long lasting anti-angiogenic peptides

Methods involving long lasting synthetic exendin-4 peptide conjugates

MVA expressing modified HIV envelope, gag, and pol genes

Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains

Albumin-fused anti-angiogenesis peptides

Regulated nucleic acid expression system

Cellular immunity test with peptides fixed on a solid support

Chimeric recombinant protein and in vitro diagnosis

Methods and compositions for inhibiting hiv-coreceptor interactions

Identification of new CD8 epitopes from HIV-1 proteins

Hiv vaccine formulations

Recombinant expression of factor VIII in human cells

Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity

Stabilized viral envelope proteins and uses thereof

Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics

Immunogens for hiv vaccine

Immunotherapy regimens in hiv-infected patients

Antimicrobial peptides and use thereof

Virus-like particles, methods of preparation, and immunogenic compositions

Chimeric virus vaccine

Hla binding peptides and their uses

Methods and compositions for promoting immunopotentiation

Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes

Synthetic glyco-lipo-peptides as vaccines

Methods involving long lasting synthetic exendin-4-peptide conjugates

DNA expression vectors and methods of use

Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods

Epitope testing using soluble HLA

Human immunodeficiency virus integrase-LEDGF p75 isoform protein-protein interactions

HIV antisense proteins

Recombinant negative strand RNA virus expression system and vacccines

Biosynthetic polypeptides utilizing non-naturally encoded amino acids

Coordinate in vivo gene expression

Igg fc/hiv-gp120/c3d fusion protien

Five-Helix protein

Composition and method for enhancing immune response

Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositions

Antigen delivery vectors and constructs

Long lasting synthetic exendin-4 peptide conjugates

Human immunodeficiency virus vaccine

Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays

Immunizing against HIV infection

Polycistronic HIV vector constructs

Fc chimeric proteins with anti-HIV drugs

Retrovirus-like particles made non-infectious by a plurality of mutations

Recombinant lentivirus encoding modified GP 120 signal sequences

Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKLIS

Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions

Novel use

Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens

Aids vaccines

Peptide inhibitors of HIV

HIV antisense proteins

Compositions and methods for modulating a cytotoxic T lymphocyte immune response

Live replicating spumavirus vector

Carbohydrate-based synthetic vaccines for HIV

Development of a murine model of HIV-1 infection on the basis of construction of EcoHIV, a chimeric, molecular clone of human immunodeficiency virus type 1 and ecotropic moloney murine leukemia virus competent to infect murine cells and mice

Mucosal cytotoxic T lymphocyte responses

Inhibition of viral infection and spread with viral and RhoA-derived peptides

Method for modification of NMDA receptors through inhibition of Src

Virus coat protein/receptor chimeras and method of use

Reference clones and sequences for non-subtype B isolates of human immunodeficiency virus type 1

Inhibitors of HIV membrane fusion

Stabilized soluble glycoprotein trimers

HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides

Immunogenic composition and method of developing a vaccine based on fusion protein

Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site

Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof

Peptides that bind to broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex. uses thereof, compositions therefrom

Preventive and therapeutic aids vaccines

Plasmids encoding therapeutic agents

Multimerised HIV fusion inhibitors

Multivalent compounds for crosslinking receptors and uses thereof

Methods for the recombinant production of antifusogenic peptides

Identifying oligonucleotides for in vitro recombination

CD4-independent HIV envelope proteins as vaccines and therapeutics

Albumin fusion proteins comprising GLP-1 polypeptides

Attenuated bovine respiratory syncytial virus

Soluble complex comprising a retroviral surface glycoprotein

Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins

Process and systems for recovery of peptides

Peptide synthesis and deprotection using a cosolvent

Methods for recovering cleaved peptide from a support after solid phase synthesis

CD8 epitope from HIV-1 protein Vpu

Synthetic conjugate of CpG DNA and T-help/CTL peptide

Peptide synthesis using filter decanting

Ancestral and COT viral sequences, proteins and immunogenic compositions

Human immunodeficiency virus gp41 mimetibody polypeptides

End of aids for general virology, based on profound science as protein foldings: safe vaccines, universal antimicrobial means, mad cow end

Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV

Alphavirus vectors and virosomes with modified HIV genes for use as vaccines

Compositions of protein mimetics and methods of using same against HIV-1, SARS-coV and the like

Soluble complexes of amylod β peptide and peptidyl prolyl isomerase chaperone and methods of making and using them

Immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) devoid of CD55 and CD59 in the viral membrane

Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide

Immunogenic composition and method of developing a vaccine based on factor H binding sites

Aids vaccines

Immunogenic composition

Stabilized soluble glycoprotein trimers

Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogens

Method of inducing an enhanced immune response against hiv

Detection of HIV-1 DNA

Human immunodeficiency virus (HIV) gp41 peptide derivatives with enhanced solubility and antiviral activity

Human immunodeficiency virus envelope clycoprotein mutants and uses thereof

Pseudomonas exotoxin A-like chimeric immunogens for eliciting a secretory IgA-mediated immune response

Determination of a specific immunoglobulin using multiple antigens

Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group

Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications

Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use

Mutated env gene, mutated env glycoprotein and the use thereof

Long lasting fusion peptide inhibitors for HIV infection

Compositions, method and kits relating to deletion mutations of immunodeficiency virus gp120 hypervariable regions

Nucleic acids encoding fusion peptides

Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv

Targeted particles and methods of using the same

Retrovirus from the HIV group and its use

Core structure of gp41 from the HIV envelope glycoprotein

Recombinant vaccinia virus vaccine

Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them

Polynucleotide encoding a mutated HIV gp41 polypeptide

Compositions and methods for peptide-assisted transfection

Method

Influenza hemagglutinin and neuraminidase variants

Recombinant negative strand RNA virus expression systems and vaccines

HIV-specific T-cell induction

HIV-1 envelope glycoproteins having unusual disulfide structure

Attenuated HIV strains and uses thereof

Molecular vector for the genophenotypic characterisation of v3 sequences of hiv-1 gp120 and process for preparation thereof

Computer-based methods of designing molecules

Vaccine compositions and methods

Methods of attaching soluble HLA to solid supports

Peptide having an affinity for gp120

Comparative ligand mapping from MHC class 1 positive cells

HIV antisense proteins